Roseann Lezell, APRN

Roseann Lezell practices at MD Now Urgent Care - Plantation in Plantation, Florida.

Roseann Lezell's NPI, 1215574124, was assigned on December 10, 2019. Roseann Lezell holds Florida license APRN11005249.

Roseann Lezell's primary practice is MD Now Urgent Care - Plantation, at 7007 W Broward Blvd, Plantation, FL 33317. The practice phone is (561) 420-8555.

Roseann Lezell's primary practice is MD Now Urgent Care - Plantation in Plantation, Florida. The medical group on file is MD Now Urgent Care. Roseann Lezell's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Roseann Lezell practices. Vendor and product names are available with a free account.

Family is Roseann Lezell's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Roseann Lezell is licensed in Florida.

Dmand AI lists acute sinusitis, acute skin infection, ankle or foot injury, bladder disease, bronchitis, conjunctivitis, contact dermatitis and ear infection among the conditions Roseann Lezell treats.

CMS data shows 230 Medicare services from Roseann Lezell across 7 procedure codes in 2024, for 195 Medicare patients. Medicare paid $13,966 for them. Every service was in an office.

CMS counts 195 Medicare patients who saw Roseann Lezell in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Roseann Lezell's median patient age at 40, with 67% women.

In 2024, Roseann Lezell wrote 601 Medicare Part D claims for 345 patients. 90% of them were for generic drugs. CMS names the drug for 398 of them, across 18 drugs with 11 or more claims each, at $17,600 in total drug cost.

Roseann Lezell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Roseann Lezell from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $26.